Abstract
Drug-device combination products (DDCPs) represent a significant area of development in modern medical treatments, combining pharmaceutical products with medical devices to improve patient outcomes. This article explores recent advances in DDCPs, including new materials, innovations in drug delivery mechanisms, regulatory challenges, and the clinical impact on patients with chronic conditions. The synergy between drug administration and device function can optimize therapeutic efficacy, reducing side effects and improving patient compliance. The article provides an overview of key trends in the field, highlighting both successes and ongoing challenges.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2021 Emily J. Hansen (Author)